DaVita
DVA
#1848
Rank
NZ$19.97 B
Marketcap
NZ$311.16
Share price
-0.36%
Change (1 day)
43.45%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$18.80

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$18.69. In 2025 the company made an earnings per share (EPS) of NZ$17.20 a decrease over its 2024 EPS that were of NZ$18.74.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$18.809.31%
2025NZ$17.20-8.25%
2024NZ$18.7444.94%
2023NZ$12.9327.26%
2022NZ$10.16-35.56%
2021NZ$15.7744.1%
2020NZ$10.9419.7%
2019NZ$9.14540.48%
2018NZ$1.43-76.07%
2017NZ$5.96-19.31%
2016NZ$7.39242.52%
2015NZ$2.16-62.87%
2014NZ$5.8113.43%
2013NZ$5.128.45%
2012NZ$4.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$41.31 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.31 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$32.95 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.51-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA